Cannex Capital Holdings Inc Share Price Canadian Securities Exchange
Equities
CA13768L1085
Pharmaceuticals
Sales 2024 * | 120M 163M 9.44B | Sales 2025 * | - | Capitalization | 97.22M 132M 7.67B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.81 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Cannex Capital Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Founder | 38 | - | |
Andrew Thut
CEO | Chief Executive Officer | 50 | 30/09/14 |
Karl Chowscano
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rob Hunt
CHM | Chairman | 51 | 11/04/22 |
Anthony Dutton
PRN | Corporate Officer/Principal | 66 | - |
Chetan Gulati
BRD | Director/Board Member | 46 | 30/11/20 |
1st Jan change | Capi. | |
---|---|---|
+45.15% | 6.34B | |
-14.00% | 4.61B | |
+9.54% | 3.39B | |
-8.99% | 3.29B | |
+50.03% | 2.02B | |
-6.97% | 1.73B | |
-0.31% | 1.67B | |
+50.00% | 1.63B | |
-10.61% | 1.59B |